Results 71 to 80 of about 265 (130)

The challenge posed by endocrine-disrupting chemicals. [PDF]

Environ Health Perspect, 1997
Ashby J, Houthoff E, Kennedy SJ, Stevens J, Bars R, Jekat FW, Campbell P, Van Miller J, Carpanini FM, Randall GL.   +9 more
europepmc   +1 more source

Human Immunoglobulins for intravenous use and hepatitis C viral transmission. [PDF]

Clin Diagn Lab Immunol, 1994
Slade HB.
europepmc   +1 more source

Evaluation of growth promotion and inhibition from mycobactins and nonmycobacterial siderophores (Desferrioxamine and FR160) in Mycobacterium aurum. [PDF]

Antimicrob Agents Chemother, 1997
Bosne-David S, Bricard L, Ramiandrasoa F, DeRoussent A, Kunesch G, Andremont A.   +5 more
europepmc   +1 more source

Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat model. [PDF]

Antimicrob Agents Chemother, 1998
Brun-Pascaud M, Rajagopalan-Levasseur P, Chau F, Bertrand G, Garry L, Derouin F, Girard PM.   +6 more
europepmc   +1 more source

PEST motifs are not required for rapid calpain-mediated proteolysis of c-fos protein. [PDF]

Biochem J, 1996
Carillo S, Pariat M, Steff Am, Jariel-Encontre I, Poulat F, Berta P, Piechaczyk M.   +6 more
europepmc   +1 more source

Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases. [PDF]

Antimicrob Agents Chemother, 1996
Blanche F, Cameron B, Bernard FX, Maton L, Manse B, Ferrero L, Ratet N, Lecoq C, Goniot A, Bisch D, Crouzet J.   +10 more
europepmc   +1 more source

Overseas doctors face new rules to work in Britain. [PDF]

BMJ, 1995
Beecham L.
europepmc   +1 more source

Francis Poulencs Elegie

, 2016
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Francis Poulenc

Osterreichische Musikzeitschrift, 1959
exaly   +2 more sources